Aethlon Medical, Inc.
Chetan Shah (Director) reports AEMD insider transactions
About this filing
Aethlon Medical, Inc. (AEMD) filed Form 4 (insider transaction) with the SEC on Oct 15, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Chetan Shah · Director
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | F · tax withholdingFootnotes F1, F2 | −436 | $6.52 | $2,842.72 | 3,787 | Direct |
Footnotes
- F1 The Reporting Person forfeited 436 shares of common stock upon conversion of an aggregate 1,091 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 17, 2026.
- F2 The amount of securities beneficially owned is being amended to account for a typographical error in the Form 4 filed on April 21, 2026. The number of shares beneficially owned following the reported transaction was shown as 23,021 shares, but should have been 23,278.
More AEMD filings
- 10-Q
Filed Nov 12, 2026
- 8-K
Filed Nov 12, 2026
- S-8
Filed Nov 12, 2026
- 4
Filed Oct 15, 2026
- 4/A
Filed Oct 15, 2026
- 4
Filed Oct 15, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.